Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
214 articles
12 of 22
Germany’s first DTx price renegotiation. Trial updates
10.15.21
4
min. Read
Anticipated launch dates for 7 PDTs. Trial updates
10.08.21
6
min. Read
Blue Shield CA on PDT medical spend. Trial updates
10.01.21
5
min. Read
Research studies and Apple’s FDA pipeline. Trial updates
9.24.21
7
min. Read
Why Premera won’t pay for PDTs. Trial updates
9.17.21
8
min. Read
Pear financials. DTx commercialization costs. Trial updates
9.10.21
8
min. Read
RTM reimbursement comments. Exec pay and trial updates
9.03.21
6
min. Read
Clinical trial updates: Amgen, Apple, Happify and more
8.27.21
5
min. Read
Details on Akili’s latest deal. Trial updates.
8.20.21
5
min. Read
Prescription Digital Therapeutic Pipeline updates.
8.13.21
6
min. Read
1 of 22